Literature DB >> 3766707

Enolase isozymes in renal tubules and renal cell carcinoma.

H Haimoto, M Takashi, T Koshikawa, J Asai, K Kato.   

Abstract

To elucidate the localization of enolase isozymes in renal tubules and renal cell carcinoma, an immunohistochemical study and quantitative analysis by employing the enzyme immunoassay were performed. The alpha-enolase was localized in almost all epithelial cells of renal tubules except for loops of Henle. The gamma-enolase was localized in macula densa cells and epithelial cells of loops of Henle and collecting ducts of the medulla, but not in those of proximal tubules. In renal cell carcinoma, most tumor cells possessed two enolase isozymes. From these immunohistochemical findings, it is suggested that enolases are present mainly in the alpha alpha form in epithelial cells of proximal tubules, in the gamma gamma form in those of loops of Henle, and in the two forms and/or the alpha gamma form in tumor cells of renal cell carcinoma. The levels of gamma-enolase in the normal cortex were 16.8 +/- 3.7 ng/mg protein (n = 7), whereas those in renal cell carcinoma were 928 +/- 554 ng/mg protein (n = 7), about 55-fold higher than those in the normal cortex. The serum gamma-enolase levels were also enhanced in 20 (49%) of 41 patients with renal cell carcinoma. Because it is generally accepted that renal cell carcinoma is derived from epithelium of proximal tubules, the expression of gamma-enolase has occurred during carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3766707      PMCID: PMC1888350     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Lectin histochemistry of kidney tumours and its pathomorphological relevance.

Authors:  W Ulrich; R Horvat; K Krisch
Journal:  Histopathology       Date:  1985-10       Impact factor: 5.087

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells.

Authors:  D Schmechel; P J Marangos; M Brightman
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

4.  Enolase isoenzymes in rat tissues. Electrophoretic, chromatographic, immunological and kinetic properties.

Authors:  C C Rider; C B Taylor
Journal:  Biochim Biophys Acta       Date:  1974-09-13

5.  Enolase isoenzymes as markers of differentiation in teratocarcinoma cells and normal tissues of mouse.

Authors:  L Fletcher; C C Rider; C B Taylor; E D Adamson; B M Luke; C F Graham
Journal:  Dev Biol       Date:  1978-08       Impact factor: 3.582

6.  Functional properties of neuronal and glial isoenzymes of brain enolase.

Authors:  P J Marangos; A M Parma; F K Goodwin
Journal:  J Neurochem       Date:  1978-09       Impact factor: 5.372

7.  Changes in the activity and isozyme patterns of glycolytic enzymes during stimulation of normal human lymphocytes with phytohaemagglutinin.

Authors:  P A Rogers; D P Brenton; D A Hopkinson
Journal:  Ann Hum Genet       Date:  1980-01       Impact factor: 1.670

8.  Recent progress in the peroxidase-labeled antibody method.

Authors:  P K Nakane
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

9.  Brain endolases as specific markers of neuronal and glial cells.

Authors:  D Schmechel; P J Marangos; A P Zis; M Brightman; F K Goodwin
Journal:  Science       Date:  1978-01-20       Impact factor: 47.728

10.  Enolase isoenzymes. III. Chromatographic and immunological characteristics of rat brain enolase.

Authors:  L Fletcher; C C Rider; C B Taylor
Journal:  Biochim Biophys Acta       Date:  1976-11-08
View more
  16 in total

1.  Aldolase C is localized in neuroendocrine cells.

Authors:  H Inagaki; H Haimoto; S Hosoda; K Kato
Journal:  Experientia       Date:  1988-09-15

2.  Immunohistochemical study of peripolar cells of the sheep.

Authors:  J F Trahair; J A Gall; D Alcorn; J P Coghlan; R Fernley; J Penschow; L P Grattage; C I Johnston; G B Ryan
Journal:  J Anat       Date:  1989-02       Impact factor: 2.610

3.  The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies.

Authors:  P O Wilson; P C Barber; Q A Hamid; B F Power; A P Dhillon; J Rode; I N Day; R J Thompson; J M Polak
Journal:  Br J Exp Pathol       Date:  1988-02

4.  Enolase isozymes in seminoma.

Authors:  M Takashi; H Haimoto; T Nagai; T Koshikawa; K Kato
Journal:  Urol Res       Date:  1990

5.  Elevated concentrations of gamma-enolase in renal cell tumors in rats: similarity to renal cell carcinoma in man.

Authors:  M Takashi; T Sakata; Y Inaguma; K Kato
Journal:  Urol Res       Date:  1996

6.  L- and M2-pyruvate kinase expression in renal cell carcinomas and their metastases.

Authors:  U Brinck; E Eigenbrodt; M Oehmke; S Mazurek; G Fischer
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Serum neuron specific enolase: can it be a tumour marker for renal cell carcinoma?

Authors:  O Yaman; S Baltaci; N Arikan; E Ozdiler; O Göğüş; Y Z Müftüoğlu
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

8.  Gamma-enolase and glial fibrillary acidic protein in nervous system tumors. An immunohistochemical study using specific monoclonal antibodies.

Authors:  P Cras; J J Martin; J Gheuens
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

9.  Elevated levels of serum aldolase A in patients with renal cell carcinoma.

Authors:  M Takashi; Y Zhu; Y Nakano; K Miyake; K Kato
Journal:  Urol Res       Date:  1992

10.  Immunocytochemical analysis of Ewing's tumors. Patterns of expression of intermediate filaments and desmosomal proteins indicate cell type heterogeneity and pluripotential differentiation.

Authors:  R Moll; I Lee; V E Gould; R Berndt; A Roessner; W W Franke
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.